![](/img/cover-not-exists.png)
Calcineurin Inhibitor (CI) Use Reduces the Risk of Donor-Specific Antibody (DSA) Development After Kidney and Kidney/pancreas Transplant.
Pelletier, R., Rajab, A., Henry, M.Volume:
98
Journal:
Transplantation
DOI:
10.1097/00007890-201407151-00375
Date:
July, 2014
File:
PDF, 282 KB
2014